These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18190823)

  • 1. Gene polymorphisms in bladder cancer.
    Franekova M; Halasova E; Bukovska E; Luptak J; Dobrota D
    Urol Oncol; 2008; 26(1):1-8. PubMed ID: 18190823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of DNA repair genes in bladder cancer.
    Kiltie AE
    Methods Mol Biol; 2009; 472():281-306. PubMed ID: 19107438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder Cancer Working Group report.
    Kakehi Y; Hirao Y; Kim WJ; Ozono S; Masumori N; Miyanaga N; Nasu Y; Yokomizo A
    Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i57-64. PubMed ID: 20870921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of N-acetyltransferase and glutathione S-transferase related to neoplasm of genitourinary system. Minireview.
    Reszka E; Wasowicz W
    Neoplasma; 2002; 49(4):209-16. PubMed ID: 12382017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1).
    Narter KF; Ergen A; Agaçhan B; Görmüs U; Timirci O; Isbir T
    Anticancer Res; 2009 Apr; 29(4):1389-93. PubMed ID: 19414392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer.
    Lin J; Kadlubar FF; Spitz MR; Zhao H; Wu X
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1832-6. PubMed ID: 16030125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular genetic model of human bladder carcinogenesis.
    Reznikoff CA; Kao C; Messing EM; Newton M; Swaminathan S
    Semin Cancer Biol; 1993 Jun; 4(3):143-52. PubMed ID: 8318690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort.
    Fontana L; Bosviel R; Delort L; Guy L; Chalabi N; Kwiatkowski F; Satih S; Rabiau N; Boiteux JP; Chamoux A; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2008; 28(3B):1853-6. PubMed ID: 18630471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population.
    Shao J; Gu M; Zhang Z; Xu Z; Hu Q; Qian L
    Int J Urol; 2008 Mar; 15(3):216-21. PubMed ID: 18304215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder cancer epidemiology and pathogenesis.
    Ross RK; Jones PA; Yu MC
    Semin Oncol; 1996 Oct; 23(5):536-45. PubMed ID: 8893866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population.
    Rouissi K; Ouerhani S; Oliveira E; Marrakchi R; Cherni L; Ben Othman F; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; Prata MJ; Benammar Elgaaied A
    Cancer Genet Cytogenet; 2009 Nov; 195(1):43-53. PubMed ID: 19837268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
    Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
    Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
    Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and genetic susceptibility to bladder cancer.
    Wu X; Ros MM; Gu J; Kiemeney L
    BJU Int; 2008 Nov; 102(9 Pt B):1207-15. PubMed ID: 19035883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of bladder and kidney cancer.
    Scélo G; Brennan P
    Nat Clin Pract Urol; 2007 Apr; 4(4):205-17. PubMed ID: 17415353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D; Mandhani A; Mittal RD
    Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide excision repair, oxidative damage, DNA sequence polymorphisms, and cancer treatment.
    Hutsell SQ; Sancar A
    Clin Cancer Res; 2005 Feb; 11(4):1355-7. PubMed ID: 15746031
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study on polymorphisms in metabolic enzyme genes, DNA repair genes and individual susceptibility to childhood leukemia].
    Zhu R; Xia Z
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):635-8. PubMed ID: 15612500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.